MétaCan
ENFR
Menu
Cohort builder

4,299,418 works, Canadian by any of four routes.

Every filter state is a URL; the URL is the query; the query is citable via /q/⟨hash⟩. The page, the API and the export parse the same parameters.

Export CSVExport JSONAPI query

The current cohort, streamed from the database: every work column, the machine labels, the provisional scores, and the per-row validation status. Exports are capped at 100,000 rows. Mints a permanent /q/ link for this exact query. The same filters always produce the same link, whoever asks.

Search term
Author
Year range
→
Sort
Language
Type
Field
Venue
Topic
Biosimilars and Bioanalytical Methods
Retraction
Abstract
Evidence source
Study design
Label agreement
Label status

Direct Codex and Gemma labels are unvalidated and sparse. Distilled predictions cover the full frame and are also unvalidated. Choose the evidence source explicitly; absence of a direct label is never a negative label.

affaffiliation
fundfunder
venuejournal
aboutaboutness

The four routes compose: require the funder route and exclude affiliation to get the funder-only stratum no affiliation-based frame ever sees.

876 results · 1 filter active ·
Results by year
20002025
Publication date
Categories
Machine labels · sparse coverage
Evidence
Language
Type
Citations
An unlabeled work is unknown, not a negative. Label coverage is reported on every query.
876 works in the cohort · of 4,299,418page 12 of 18

Labels cover 4 of 876 works in this cohort. The rest are unlabeled, which is not a negative label: the label table is sparse today and grows as labeling rounds land.

Distilled predictions cover 876 of 876 works in this cohort. Predictions are machine_predicted_unvalidated teacher distillation outputs. Candidate is the union; consensus is the intersection.

fundno affunlabeled
4CPS-254 Biosimilar rituximab – a year beyond
Mafalda Sá Pereira, Giovanna de Oliveira Sá Costa, S Domingos-Camões, A Alcobia
2019· article· en· Section 4: Clinical pharmacy services· Immunology and Microbiology
distilled prediction:candidate · insufficient_payloadconsensus · insufficient_payload
1
citations
affvenueaboutunlabeled
Revising the Guidance Document for Biosimilar Agents
Steven Williams
2017· article· fr· Health Reform Observer - Observatoire des Réformes de Santé· Immunology and Microbiology
distilled prediction:candidate · metaepi_narrow+stsconsensus · none
1
citations
affunlabeled
Clinical Validation and Biomarker Translation
David Lin, Andreas Scherer, Raymond T. Ng, Robert Balshaw, Shawna Flynn, Paul Keown +2 more
2010· other· en· Pharmaceutical Sciences Encyclopedia· Immunology and Microbiology
distilled prediction:candidate · insufficient_payloadconsensus · none
1
citations
affno abstractunlabeled
Letter to the Editor
Kelly Matsuda
2009· letter· en· Hospital Pharmacy· Immunology and Microbiology
distilled prediction:candidate · research_integrity+insufficient_payloadconsensus · insufficient_payload
1
citations
venueno affno abstractunlabeled
10.1016/s1553-3212(07)70050-x
2000· article· en· Time to knit· Immunology and Microbiology
distilled prediction:candidate · insufficient_payloadconsensus · insufficient_payload
0
citations
aboutno affno abstractunlabeled
Biosimilars regulations: Updates from Canada
Oxana Iliach
2016· article· en· Journal of Bioanalysis & Biomedicine· Immunology and Microbiology
distilled prediction:candidate · insufficient_payloadconsensus · none
0
citations
venueno affno abstractunlabeled
10.1016/s1541-9800(07)70327-7
2000· article· en· Time to knit· Immunology and Microbiology
distilled prediction:candidate · insufficient_payloadconsensus · insufficient_payload
0
citations
affno abstractunlabeled
The Pharmacodynamic Effects of Rituximab at Very Low Doses
Christian Schoergenhofer, Christa Firbas, Ulla Derhaschnig, Robert M. Mader, Raute Sunder‐Plaßmann, Petra Jilma‐Stohlawetz +4 more
2017· article· en· Clinical Therapeutics· Immunology and Microbiology
distilled prediction:candidate · noneconsensus · none
0
citations
venueno affno abstractunlabeled
10.1016/s1541-9800(09)70188-7
2000· article· en· Time to knit· Immunology and Microbiology
distilled prediction:candidate · insufficient_payloadconsensus · insufficient_payload
0
citations
affno abstractunlabeled
SAT0195 Rituximab shows better sustainability than tnf inhibitors when used following initial biologic dmard failure in the treatment of rheumatoid arthritis: 8 years of real-world observations from the rhumadata® clinical database and registry
D Choquette, L Bessette, B Haraoui, F Massicotte, J-P Pelletier, J. P. Raynauld +5 more
2017· article· en· Annals of the Rheumatic Diseases· Immunology and Microbiology
distilled prediction:candidate · noneconsensus · none
0
citations
aboutno affunlabeled
Potential Concerns and Questions
Gerhard Rogler
2015· book-chapter· en· Frontiers of gastrointestinal research· Immunology and Microbiology
distilled prediction:candidate · stsconsensus · none
0
citations
affunlabeled
CFdb: chromatograms
Michael A. Skinnider
2023· dataset· en· Zenodo (CERN European Organization for Nuclear Research)· Immunology and Microbiology
distilled prediction:candidate · metaepi_narrow+sts+insufficient_payloadconsensus · insufficient_payload
0
citations
← previousnext →

How this was built: Screen · Findings · About